Samir Kaul - 15 Jun 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John J. Demeter, as attorney-in-fact for Samir Kaul
Issuer symbol
GH
Transactions as of
15 Jun 2022
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 17:54:57 UTC
Previous filing
03 Jun 2022
Next filing
11 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +1,814 +45% $0.000000 5,873 15 Jun 2022 Direct
holding GH COMMON STOCK 4,943 15 Jun 2022 By Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -1,814 -100% $0.000000* 0 15 Jun 2022 COMMON STOCK 1,814 $0.000000 Direct F2, F3
transaction GH STOCK OPTION (RIGHT TO BUY) Award $0 +8,789 $0.000000 8,789 15 Jun 2022 COMMON STOCK 8,789 $38.42 Direct F4
transaction GH RESTRICTED STOCK UNITS Award $0 +5,531 $0.000000 5,531 15 Jun 2022 COMMON STOCK 5,531 $0.000000 Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family.
F2 The Restricted Stock Units vest in full on the one-year anniversary of the grant date, June 15th, 2022.
F3 Not applicable for Restricted Stock Units.
F4 The Stock Options vest in full on the one-year anniversary of the grant date, June 15th, 2023.
F5 The Restricted Stock Units vest in full on the one-year anniversary of the grant date, June 15th, 2023.